Quantumzyme Corp. (OTCQB: QTZM), a global leader in computational enzyme engineering and digital biocatalysis, today announced the expansion of its proprietary AI-powered enzyme design platform to ...
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma ...
Key drivers of this growth include the rising incidence of degenerative bone diseases, diabetic ulcers, traumatic injuries, sports-related ...
Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's ...
Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...
Standard Glass Lining Technology Limited announced its results for the second quarter of FY26, marking another significant ...
Lake Geneva–based Plas-Tech Engineering, a maker of custom medical and pharmaceutical components, has been acquired by ...
The global protein engineering market size is calculated at USD 3.58 billion in 2025 and is expected to reach around USD ...
(MENAFN- PR Newswire) Purpose-built to optimise the production of plasma-derived therapies for conditions such as immunodeficiencies, neurological disorders, and burns, the Broadmeadows facility ...
Drug-delivery device manufacturer H&T Presspart, a division of the Heitkamp & Thumann Group, announced this week that it has ...
THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS ...
The company previously announced the publication of its U.S. Patent Application ( U.S. Patent Application Publication No. US 2025/0146029 A1) covering related enzymatic processes. Together, these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback